Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
12,116
Price
$18.21
Total Value
$220.63K
Shares Held After
339,254
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Loomis David K — Chief Accounting Officer
Shares
1,016
Price
$11.89
Total Value
$12.08K
Shares Held After
30,800
% of Holdings
3.2%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
5,685
Price
$11.89
Total Value
$67.59K
Shares Held After
163,938
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
4,592
Price
$11.89
Total Value
$54.60K
Shares Held After
151,232
% of Holdings
2.9%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,134
Price
$11.89
Total Value
$61.04K
Shares Held After
159,267
% of Holdings
3.1%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
4,403
Price
$11.89
Total Value
$52.35K
Shares Held After
154,482
% of Holdings
2.8%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
12,279
Price
$3.31
Total Value
$40.67K
Shares Held After
1,052,045
% of Holdings
1.2%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
3,726
Price
$3.31
Total Value
$12.34K
Shares Held After
92,176
% of Holdings
3.9%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
12,253
Price
$3.31
Total Value
$40.58K
Shares Held After
683,376
% of Holdings
1.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$26.49
Total Value
$5.30M
Shares Held After
1,654,597
% of Holdings
10.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
13,871
Price
$7.78
Total Value
$107.95K
Shares Held After
174,316
% of Holdings
7.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
57,952
Price
$1.31
Total Value
$75.88K
Shares Held After
1,443,641
% of Holdings
4.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
4,701
Price
$7.78
Total Value
$36.59K
Shares Held After
96,694
% of Holdings
4.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$499.99
Total Value
$749.99K
Shares Held After
46,132
% of Holdings
3.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
291
Price
$63.00
Total Value
$18.33K
Shares Held After
450,335
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
266
Price
$500.00
Total Value
$133.00K
Shares Held After
4,299
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
988
Price
$499.00
Total Value
$493.01K
Shares Held After
16,838
% of Holdings
5.5%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,530
Price
$7.79
Total Value
$11.92K
Shares Held After
47,872
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
23,305
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
59,802
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
31,769
% of Holdings
5.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
6,958
Price
$310.08
Total Value
$2.16M
Shares Held After
85,662
% of Holdings
7.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
24,848
% of Holdings
8.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$102.09
Total Value
$204.18K
Shares Held After
0
% of Holdings
100.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
10,000
Price
$5.81
Total Value
$58.14K
Shares Held After
204,657
% of Holdings
4.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.58
Total Value
$175.10K
Shares Held After
44,089
% of Holdings
12.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
4,166
Price
$27.33
Total Value
$113.86K
Shares Held After
50,437
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,541
Price
$27.33
Total Value
$96.78K
Shares Held After
50,437
% of Holdings
6.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,207
Price
$82.07
Total Value
$509.40K
Shares Held After
32,105
% of Holdings
16.2%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
9,435
Price
$81.56
Total Value
$769.51K
Shares Held After
38,312
% of Holdings
19.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
10,348
Price
$9.04
Total Value
$93.55K
Shares Held After
332,412
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
124,882
Price
$9.04
Total Value
$1.13M
Shares Held After
3,033,078
% of Holdings
4.0%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
11,446
Price
$9.04
Total Value
$103.47K
Shares Held After
366,356
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
7,863
Price
$9.04
Total Value
$71.08K
Shares Held After
318,417
% of Holdings
2.4%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
90,000
Price
$5.23
Total Value
$470.99K
Shares Held After
214,657
% of Holdings
29.5%
Entera Bio Ltd. (ENTX)
Rubin Steven D — Director
Shares
5,000
Price
$1.49
Total Value
$7.45K
Shares Held After
15,000
% of Holdings
33.3%
ZIVO Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
20,000
Price
$9.77
Total Value
$195.40K
Shares Held After
472,942
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Showing 1801–1850 of 3515 transactions (page 37 of 71)